NME1 and metastatic malignant neoplasm in the lymph nodes: nm23 was expressed in normal breast tissue as well as in node negative IDC breast cancer, node negative ILC breast cancer, node positive IDC breast cancer, and matched lymph node metastasis in 85.7%, 97.5%, 61%, 92.1%, and 89.2% cases respectively.